Cas:99976-73-5 1-cyclohexylpiperazin-2-one manufacturer & supplier

We serve Chemical Name:1-cyclohexylpiperazin-2-one CAS:99976-73-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-cyclohexylpiperazin-2-one

Chemical Name:1-cyclohexylpiperazin-2-one
CAS.NO:99976-73-5
Synonyms:1-cyclohexyl-2-piperazinone;1-Cyclohexyl-piperazin-2-one;1-Cyclohexyl-2-oxo-piperazin;HMS1697O06;2-Oxo-1-cyclohexyl-piperazin
Molecular Formula:C10H18N2O
Molecular Weight:182.26300
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:32.34000
Exact Mass:182.14200
LogP:1.01760

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-cyclohexyl-2-piperazinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Oxo-1-cyclohexyl-piperazin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Cyclohexyl-2-oxo-piperazin Use and application,1-Cyclohexyl-piperazin-2-one technical grade,usp/ep/jp grade.


Related News: They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 1-cyclohexylpiperazin-2-one manufacturer There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 1-cyclohexylpiperazin-2-one supplier They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 1-cyclohexylpiperazin-2-one vendor But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. 1-cyclohexylpiperazin-2-one factory With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.